Contract Pharmaceutical Manufacturing Market 2019 Global Industry Overview and Competitive Analysis Research Report to 2025
Contract Pharmaceutical Manufacturing refers to accept commissioned from pharmaceutical companies, provide the service about API production, agent production, packaging and son on which required for pharmaceutical manufacturing.
The contract pharmaceutical manufacturing industry is not very concentrated the revenue of top eighteenth manufacturers account about 22% of global revenue.
In the world wide, the major manufactures mainly distribute in North America and Europe. The transnational companies, like Catalent and DPx, are the leading manufactures in the World.
Get Sample Copy of this Report – https://www.orianresearch.com/request-sample/723920
North America and Europe is the industry\'s leading region. In 2015, the revenue of contract pharmaceutical manufacturing is about 19 billion USD in North America; its proportion of total global revenue exceeds 32%. In 2015, the revenue is about 14 billion USD in Europe. Japan and India have witnessed a major chunk developing of the contract pharmaceutical manufacturing in the Asia region. Especially India, its revenue is 8 billion USD in 2015.
The worldwide market for Contract Pharmaceutical Manufacturing is expected to grow at a CAGR of roughly 5.8% over the next five years, will reach 96400 million US$ in 2024, from 68700 million US$ in 2019.
Scope of the Report:
Contract Pharmaceutical Manufacturing refers to accept commissioned from pharmaceutical companies, provide the service about API production, agent production, packaging and so on, which required for pharmaceutical manufacturing. The main type of contract pharmaceutical manufacturing is API and FDF.
Market Segment by Regions, regional analysis covers:
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers:
Market Segment by Applications, can be divided into:
- Big Pharma
Market Segment by Manufacturers, this report covers
- Piramal Healthcare
- Boehringer Ingelheim
- Fareva Holding
The content of the study subjects, includes a total of 15 chapters:
- Chapter 1, to describe Contract Pharmaceutical Manufacturing product scope, market overview, market opportunities, market driving force and market risks.
- Chapter 2, to profile the top manufacturers of Contract Pharmaceutical Manufacturing, with price, sales, revenue and global market share of Contract Pharmaceutical Manufacturing in 2017 and 2018.
- Chapter 3, the Contract Pharmaceutical Manufacturing competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
- Chapter 4, the Contract Pharmaceutical Manufacturing breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
- Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
- Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
- Chapter 12, Contract Pharmaceutical Manufacturing market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
- Chapter 13, 14 and 15, to describe Contract Pharmaceutical Manufacturing sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Orian Research is one of the most comprehensive collections of market intelligence reports on the World Wide Web. Our reports repository boasts of over 500000+ Industry and country research reports from over 100 top publishers. We continuously update our repository so as to provide our clients easy access to the world’s most complete and current database of expert insights on global industries, companies, and products. We also specialize in custom research in situations where our syndicate research offerings do not meet the specific requirements of our esteemed clients.
Vice President – Global Sales & Partner Relations
Orian Research Consultants
US: +1 (415) 830-3727 | UK: +44 020 8144-71-27
Follow Us on LinkedIn: https://www.linkedin.com/company-beta/13281002/